Related Experiment Video
Updated: Nov 2, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
[COVID-19 - The vaccine miracle must include strictness and caution]
1Professeur honoraire, Paris, France.
Abstract:
Outside of SARS-CoV-2 vaccines, there is little positive outlook for the control of Covid-19 epidemic. Schematically, two antagonistic and extreme strategies have been proposed, zero-covid and herd immunity. Between the two, often oscillating measures, based on medical but also societal and political considerations, have been taken without any major effect on the course of the epidemic. Vaccines are a game-changer by providing a real opportunity to sustainably protect everyone against infection and eliminate the circulation of the virus. The Pfizer, Moderna and AstraZeneca vaccines, the three currently authorized in France, overall induce remarkable protection rates of 95 %, 94 % and 70 % respectively. The surprise came from that this efficacy was obtained after a rapid development, by targeting only the viral protein S as antigen, and by using the administration of expression vectors innovative in vaccinology, consisting of either messenger RNA or recombinant adenovirus. However, bringing the epidemic under control requires a well-organized mass vaccination campaign. It also requires careful monitoring of many parameters such as the occurrence of adverse events, duration of induced immunity, vaccine efficacy against emerging variants of SARS-CoV-2, interest or not of vaccinating people already infected, vaccination of immunocompromised patients. Vaccination must be accompanied by the maintenance of barrier measures and gestures and an amplification of clinical and biological investigations both to validate its effectiveness on the Covid-19 epidemic and to prepare for future developments in vaccinology.
More Related Videos
Related Concept Videos
Preclinical Development: Overview
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

